Skip to main content

Table 2 Distribution of the CCND1, MHC-I and antigen-presenting related gene expression, and their spearman correlation

From: BRCA1 mRNA expression modifies the effect of T cell activation score on patient survival in breast cancer

  CCND1 (N = 1088)
Variable N Median Range Correlation (95% CI) p value
T cell activation score     −0.17 (− 0.22, − 0.11) < 0.0001
HLA-A 1088 14,636 1290–186,441 − 0.26 (− 0.32, − 0.21) < 0.0001
HLA-B 1088 22,385 2013–373,873 − 0.27 (− 0.33, − 0.22) < 0.0001
HLA-C 1088 16,592 1455–224,187 − 0.21 (− 0.26, − 0.15) < 0.0001
ERAP1 1088 1416 94–7157 0.05 (− 0.01, 0.11) 0.109
ERAP2 1088 643 4.5–6506 −0.08 (− 0.14, − 0.02) 0.0098
TAP1 1088 2259 205–41,853 − 0.26 (− 0.31, − 0.20) < 0.0001
TAP2 1088 1148 117–15,665 −0.30 (− 0.35, − 0.24) < 0.0001
TAPBP 1088 5193 1307–24,371 −0.16 (− 0.21, − 0.10) < 0.0001
CCND1 1088 7925 129–245,328